Achieving hypoxia-inducible gene expression in tumors
Related Experiment Video
Updated: Aug 18, 2026
Induction and Testing of Hypoxia in Cell Culture
Published on: August 12, 2011
L Marignol1, M Lawler, Mary Coffey
1Department of Haematology and Academic Unit of Clinical and Molecular Oncology, Institute of Molecular Medicine, St. James's Hospital and Trinity College, Dublin, Ireland.
Abstract:
Hypoxia is an inevitable feature of solid tumors and a common cause of treatment failure. Hypoxia acts as a trigger to genetic instability, apoptosis and possibly metastases. The adaptive response to cellular hypoxia involves the modulation of the synthesis of multiple proteins controlling processes such as glucose homeostasis, angiogenesis, vascular permeability and inflammation. The hypoxia responsive element (HRE) sequences isolated from oxygen-responsive genes have been shown to selectively induce gene expression in response to hypoxia when placed upstream of a promoter. The levels of induced gene expression were dependent on the number of HRE copies and the oxygen tension. Hypoxia-mediated cancer gene therapy strategies may represent a promising mean to significantly improve the efficacy of standard radiation therapy and chemotherapy approaches.
Insights
Solid tumors often feature hypoxia, hindering cancer treatment. Hypoxia-responsive elements (HREs) can selectively control gene expression, offering a promising strategy for hypoxia-mediated cancer gene therapy.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Genetics
Background:
- Hypoxia, or low oxygen, is a hallmark of solid tumors and a primary driver of treatment resistance.
- Tumor hypoxia promotes genetic instability, apoptosis, and metastasis.
- Cellular adaptation to hypoxia involves regulating proteins controlling glucose metabolism, angiogenesis, vascular permeability, and inflammation.
Purpose of the Study:
- To investigate the potential of hypoxia-responsive elements (HREs) for targeted gene expression in hypoxic tumors.
- To explore hypoxia-mediated cancer gene therapy as a strategy to enhance conventional cancer treatments.
Main Methods:
- Identification and isolation of hypoxia-responsive element (HRE) sequences from oxygen-responsive genes.
- Placement of HRE sequences upstream of a promoter to drive gene expression.
- Evaluation of gene induction levels based on HRE copy number and oxygen tension.
Main Results:
- HRE sequences selectively induced gene expression in response to hypoxia.
- The degree of gene induction correlated with the number of HRE copies and the level of oxygen tension.
- Hypoxia-mediated gene expression modulation was demonstrated.
Conclusions:
- Hypoxia-responsive elements offer a mechanism for targeted gene expression in hypoxic tumor environments.
- Hypoxia-mediated cancer gene therapy presents a promising approach to augment the effectiveness of radiation and chemotherapy.
- Targeting tumor hypoxia through gene therapy could overcome treatment resistance and improve patient outcomes.
Related Concept Videos
02:53Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
01:24Regulation of Angiogenesis and Blood Supply
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...